Dr. Webb completed his graduate training at the University of British Columbia and spent several years working in industry before becoming a faculty member at the University of Ottawa.  Following this, he returned to industry and developed an interest in vaccines for human malignancies.  Dr. Webb joined the Deeley Research Centre as the T cell Projects Leader continuing his work in cancer immunotherapy.  In addition, Dr. Webb has been studying new vaccine strategies to induce T cell-mediated immune responses.

  • T cell recognition of epitopes containing post-translational modifications

  • Cellular immunology, antigen discovery, vaccine development

Back to top